Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Beta Bionics, Inc.BBNX · Entity 2350 | Director | May 21, 2026 | May 26, 2026 |
| Wright Medical Group N.V.WMGI · Entity 145358 | Director | March 31, 2017 | April 03, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Beta Bionics, Inc.
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 32,209 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 16,965 · Balance 32,209 F1: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.
Wright Medical Group N.V.
Report date March 31, 2017 · Filed April 03, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative | Direct | 9,283 |
Reported balance
After 2017-03-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-03-31 · Tax withholding · Disposed 179 · Balance 9,283 F1: Includes 4,977 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 4,977 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 26, 2026 22:00 UTC | Beta Bionics, Inc. BBNX · Entity 2350 | GrantCommon Stock | 16,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001239312-26-000003 · form4-05262026_060524.xml · nonDerivative · entry 1 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,209 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 01:30 UTC | Beta Bionics, Inc. BBNX · Entity 2350 | GrantCommon Stock | 3,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001239312-26-000002 · form4-01142026_080108.xml · nonDerivative · entry 1 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,244 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:00 UTC | Beta Bionics, Inc. BBNX · Entity 2350 | GrantCommon Stock | 11,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008533 · form4-03182025_080301.xml · nonDerivative · entry 1 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,247 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC | Beta Bionics, Inc. BBNX · Entity 2350 | GrantDirector Stock Option (right to buy) · Derivative | 30,456 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001415889-25-002815 · form4-02032025_080201.xml · derivative · entry 2 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,456 Underlying: Common Stock · 30,456 shares Expires 2032-07-26 F3 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from July 27, 2022. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC | Beta Bionics, Inc. BBNX · Entity 2350 | GrantDirector Stock Option (right to buy) · Derivative | 55,837 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001415889-25-002815 · form4-02032025_080201.xml · derivative · entry 1 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,837 Underlying: Common Stock · 55,837 shares Expires 2030-05-14 F1 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from February 12, 2020. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| March 31, 2017 Filed Apr 3, 2017 16:05 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Tax withholdingOrdinary Shares, par value EUR 0.03 per share | 179 | $31.12 | $5,570.48 |
DisclosureSEC source: 0001235802-17-000041 · primary_doc.xml · nonDerivative · entry 1 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,283 F1 · balance_after: Includes 4,977 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document |
| December 31, 2016 Filed Jan 3, 2017 16:51 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Tax withholdingOrdinary Shares, par value EUR 0.03 per share | 321 | $22.98 | $7,376.58 |
DisclosureSEC source: 0001235802-17-000002 · primary_doc.xml · nonDerivative · entry 1 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,462 F1 · balance_after: Includes 5,860 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 17:32 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Exercise / conversionStock Option (right to buy) · Derivative | 5,509 | $20.62 Strike: $20.62 | $113,595.58 |
DisclosureSEC source: 0001235802-16-000326 · primary_doc.xml · derivative · entry 10 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,509 Underlying: Ordinary Shares · 5,509 shares Expires 2025-10-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option vests in two annual installments, on the one-year and two-year anniversaries of October 13, 2015. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 17:32 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Exercise / conversionStock Option (right to buy) · Derivative | 6,034 | $21.66 Strike: $21.66 | $130,696.44 |
DisclosureSEC source: 0001235802-16-000326 · primary_doc.xml · derivative · entry 9 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,034 shares Expires 2024-08-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option has fully vested. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 17:32 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Exercise / conversionStock Option (right to buy) · Derivative | 7,538 | $19.45 Strike: $19.45 | $146,614.10 |
DisclosureSEC source: 0001235802-16-000326 · primary_doc.xml · derivative · entry 8 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,538 shares Expires 2023-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option has fully vested. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 17:32 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Exercise / conversionStock Option (right to buy) · Derivative | 6,448 | $18.04 Strike: $18.04 | $116,321.92 |
DisclosureSEC source: 0001235802-16-000326 · primary_doc.xml · derivative · entry 7 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,448 shares Expires 2022-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option has fully vested. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 17:32 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 29,219 | $22.85 | $667,566.49 |
DisclosureSEC source: 0001235802-16-000326 · primary_doc.xml · nonDerivative · entry 6 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,783 F3 · kind: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.7900 to $22.9500 inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. F1 · balance_after: Includes 6,743 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 17:32 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 25,529 | $22.79 | $581,887.60 |
DisclosureSEC source: 0001235802-16-000326 · primary_doc.xml · nonDerivative · entry 5 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,002 F2 · kind: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.6850 to $22.9150 inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F1 · balance_after: Includes 6,743 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 17:32 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Exercise / conversionOrdinary Shares, par value EUR 0.03 per share | 5,509 | $20.62 | $113,595.58 |
DisclosureSEC source: 0001235802-16-000326 · primary_doc.xml · nonDerivative · entry 4 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,743 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 17:32 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Exercise / conversionOrdinary Shares, par value EUR 0.03 per share | 6,034 | $21.66 | $130,696.44 |
DisclosureSEC source: 0001235802-16-000326 · primary_doc.xml · nonDerivative · entry 3 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,743 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 17:32 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Exercise / conversionOrdinary Shares, par value EUR 0.03 per share | 7,538 | $19.45 | $146,614.10 |
DisclosureSEC source: 0001235802-16-000326 · primary_doc.xml · nonDerivative · entry 2 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,743 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 17:32 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Exercise / conversionOrdinary Shares, par value EUR 0.03 per share | 6,448 | $18.04 | $116,321.92 |
DisclosureSEC source: 0001235802-16-000326 · primary_doc.xml · nonDerivative · entry 1 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,743 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document |
| October 13, 2016 Filed Oct 17, 2016 16:04 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Tax withholdingOrdinary Shares, par value EUR 0.03 per share | 1,177 | $23.71 | $27,906.67 |
DisclosureSEC source: 0001235802-16-000315 · primary_doc.xml · nonDerivative · entry 1 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,002 F1 · balance_after: Includes 6,743 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 19:44 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Tax withholdingOrdinary Shares, par value EUR 0.03 per share | 132 | $24.53 | $3,237.96 |
DisclosureSEC source: 0001235802-16-000311 · primary_doc.xml · nonDerivative · entry 1 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,179 F1 · balance_after: Includes 10,551 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.